The predictors of long-COVID in the cohort of Turkish Thoracic Society- TURCOVID multicenter registry: One year follow-up results

dc.authoridAvkan-Oguz, Vildan/0000-0001-7648-7730
dc.authoridFakılı, Füsun/0000-0002-1602-5240
dc.authoridKöktürk, Nurdan/0000-0002-2889-7265
dc.authoridKayalar, Özgecan/0000-0001-9107-2381
dc.authoridBAYDAR TOPRAK, OYA/0000-0001-7320-976X
dc.authoridergan, begum/0000-0003-2920-9214
dc.authoridyildiz gülhan, pinar/0000-0002-5347-2365
dc.authorwosidTutuncu, Yildiz/ACR-1309-2022
dc.authorwosidAvkan-Oguz, Vildan/ACI-2534-2022
dc.authorwosidKöktürk, Nurdan/AFS-1706-2022
dc.authorwosidFakılı, Füsun/ABV-9256-2022
dc.authorwosidKayalar, Özgecan/M-4206-2019
dc.authorwosidBAYDAR TOPRAK, OYA/U-9880-2018
dc.authorwosidergan, begum/U-8276-2017
dc.contributor.authorArgun Barış, Serap
dc.contributor.authorToprak, Oya Baydar
dc.contributor.authorÇetinkaya, Pelin Duru
dc.contributor.authorFakılı, Füsun
dc.contributor.authorKöktürk, Nurdan
dc.contributor.authorKul, Seval
dc.contributor.authorKayalar, Özgecan
dc.date.accessioned2023-07-26T11:50:47Z
dc.date.available2023-07-26T11:50:47Z
dc.date.issued2022
dc.departmentDÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göğüs Hastalıkları Ana Bilim Dalıen_US
dc.description.abstractObjective: To evaluate long-term effects of COVID-19, and to determine the risk factors in long-COVID in a cohort of the Turkish Thoracic Society (TTS)-TURCOVID multicenter registry.Methods: Thirteen centers participated with 831 patients; 504 patients were enrolled after exclusions. The study was designed in three-steps: (1) Phone questionnaire; (2) retrospective evaluation of the medical records; (3) face-to-face visit. Results: In the first step, 93.5% of the patients were hospitalized; 61.7% had a history of pneumonia at the time of diagnosis. A total of 27.1% reported clinical symptoms at the end of the first year. Dyspnea (17.00%), fatigue (6.30%), and weakness (5.00%) were the most prevalent long-term symptoms. The incidence of long-term symptoms was increased by 2.91 fold (95% CI 1.04-8.13, P=0.041) in the presence of chronic obstructive pulmonary disease and by 1.84 fold (95% CI 1.10-3.10, P=0.021) in the presence of pneumonia at initial diagnosis, 3.92 fold (95% Cl 2.29-6.72, P=0.001) of dyspnea and 1.69 fold (95% Cl 1.02-2.80, P=0.040) fatigue persists in the early-post-treatment period and 2.88 fold (95% Cl 1.52- 5.46, P=0.001) in the presence of emergency service admission in the post COVID period. In step 2, retrospective analysis of 231 patients revealed that 1.4% of the chest X-rays had not significantly improved at the end of the first year, while computed tomography (CT) scan detected fibrosis in 3.4%. In step 3, 138 (27.4%) patients admitted to face-to-face visit at the end of first year; at least one symptom persisted in 49.27% patients. The most common symptoms were dyspnea (27.60%), psychiatric symptoms (18.10%), and fatigue (17.40%). Thorax CT revealed fibrosis in 2.4% patients. Conclusions: COVID-19 symptoms can last for extended lengths of time, and severity of the disease as well as the presence of comorbidities might contribute to increased risk. Long-term clinical issues should be regularly evaluated after COVID-19.en_US
dc.identifier.doi10.4103/1995-7645.354422
dc.identifier.endpage409en_US
dc.identifier.issn1995-7645
dc.identifier.issn2352-4146
dc.identifier.issue9en_US
dc.identifier.scopus2-s2.0-85139758970en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage400en_US
dc.identifier.urihttps://doi.org/10.4103/1995-7645.354422
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12428
dc.identifier.volume15en_US
dc.identifier.wosWOS:000868945200005en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorErçelik, Merve
dc.institutionauthorGülhan, Pınar Yıldız
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofAsian Pacific Journal of Tropical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectLong Covid-19; Dyspnea; Fatigue; Comorbidityen_US
dc.subjectSurvivorsen_US
dc.titleThe predictors of long-COVID in the cohort of Turkish Thoracic Society- TURCOVID multicenter registry: One year follow-up resultsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12428.pdf
Boyut:
586.28 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text